title: Supportive care in multiple myeloma.
abstract: Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.
authors.affiliation: Roswell Park Cancer Institute, Buffalo, NY 14263, USA. asher.chanan-khan@roswellpark.org
authors.forename: Asher
authors.initials: A
authors.lastname: Chanan-Khan
authors.forename: Kena C
authors.initials: KC
authors.lastname: Miller
mesh_terms: D000740:Anemia / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001847:Bone Diseases / Q000209:etiology; D018572:Disease-Free Survival; D005221:Fatigue / Q000209:etiology; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D010166:Palliative Care; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal